Cash Flow Statement
Growth Metrics

Elevance Health (ELV) Cash & Current Investments (2016 - 2026)

Elevance Health (ELV) has disclosed Cash & Current Investments for 17 consecutive years, with $35.4 billion as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 5.63% to $35.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $35.4 billion through Dec 2025, up 5.63% year-over-year, with the annual reading at $35.4 billion for FY2025, 5.63% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $35.4 billion at Elevance Health, up from $9.9 billion in the prior quarter.
  • The five-year high for Cash & Current Investments was $37.8 billion in Q1 2023, with the low at $6.8 billion in Q4 2023.
  • Average Cash & Current Investments over 5 years is $22.7 billion, with a median of $32.4 billion recorded in 2021.
  • The sharpest move saw Cash & Current Investments tumbled 79.74% in 2023, then soared 395.77% in 2024.
  • Over 5 years, Cash & Current Investments stood at $6.8 billion in 2021, then skyrocketed by 393.11% to $33.3 billion in 2022, then crashed by 79.74% to $6.8 billion in 2023, then skyrocketed by 395.77% to $33.5 billion in 2024, then grew by 5.63% to $35.4 billion in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $35.4 billion, $9.9 billion, and $33.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.